Warby Parker (WRBY) Competitors $14.23 -0.55 (-3.72%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock WRBY vs. STVN, GKOS, NARI, INSP, BLCO, SLNO, IRTC, PRCT, NVST, and TMDXShould you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. Warby Parker vs. Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb Soleno Therapeutics iRhythm Technologies PROCEPT BioRobotics Envista TransMedics Group Stevanato Group (NYSE:STVN) and Warby Parker (NYSE:WRBY) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, community ranking, valuation and earnings. Is STVN or WRBY more profitable? Stevanato Group has a net margin of 10.47% compared to Warby Parker's net margin of -4.39%. Stevanato Group's return on equity of 9.86% beat Warby Parker's return on equity.Company Net Margins Return on Equity Return on Assets Stevanato Group10.47% 9.86% 5.79% Warby Parker -4.39%-8.26%-4.37% Do analysts rate STVN or WRBY? Warby Parker has a consensus price target of $22.71, suggesting a potential upside of 59.62%. Given Warby Parker's higher probable upside, analysts plainly believe Warby Parker is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71Warby Parker 0 Sell rating(s) 6 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.69 Do institutionals and insiders believe in STVN or WRBY? 93.2% of Warby Parker shares are held by institutional investors. 0.7% of Stevanato Group shares are held by company insiders. Comparatively, 26.5% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has stronger valuation & earnings, STVN or WRBY? Stevanato Group has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStevanato Group$1.10B6.05$157.62M$0.4845.94Warby Parker$771.32M1.91-$63.20M-$0.17-83.71 Does the MarketBeat Community believe in STVN or WRBY? Warby Parker received 16 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 62.50% of users gave Stevanato Group an outperform vote while only 44.23% of users gave Warby Parker an outperform vote. CompanyUnderperformOutperformStevanato GroupOutperform Votes3062.50% Underperform Votes1837.50% Warby ParkerOutperform Votes4644.23% Underperform Votes5855.77% Does the media favor STVN or WRBY? In the previous week, Warby Parker had 12 more articles in the media than Stevanato Group. MarketBeat recorded 18 mentions for Warby Parker and 6 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.22 beat Warby Parker's score of 0.40 indicating that Stevanato Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Warby Parker 6 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more risk and volatility, STVN or WRBY? Stevanato Group has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2, meaning that its share price is 100% more volatile than the S&P 500. SummaryStevanato Group beats Warby Parker on 11 of the 19 factors compared between the two stocks. Remove Ads Get Warby Parker News Delivered to You Automatically Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WRBY vs. The Competition Export to ExcelMetricWarby ParkerOphthalmic goods IndustryStaples SectorNYSE ExchangeMarket Cap$1.47B$10.68B$16.88B$18.33BDividend YieldN/A0.96%3.02%4.23%P/E Ratio-52.7034.6315.0730.99Price / Sales1.912.663.6925.38Price / CashN/A14.5316.3917.53Price / Book4.622.236.224.26Net Income-$63.20M$224.27M$731.54M$1.02B7 Day Performance-14.38%-5.63%0.36%-1.29%1 Month Performance-30.57%-17.22%-1.77%-7.34%1 Year Performance12.76%-26.93%-1.45%1.23% Warby Parker Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WRBYWarby Parker3.3283 of 5 stars$14.23-3.7%$22.71+59.6%+13.5%$1.47B$771.32M-52.703,030Analyst ForecastSTVNStevanato Group1.7937 of 5 stars€19.23+1.1%N/A-23.5%$5.82B$1.10B40.914,650Positive NewsGKOSGlaukos4.5397 of 5 stars$85.87+2.7%$163.25+90.1%-2.4%$4.86B$383.48M-29.92780Analyst ForecastNews CoverageHigh Trading VolumeNARIInari Medical0.3502 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800INSPInspire Medical Systems4.6292 of 5 stars$149.72+5.5%$226.70+51.4%-34.3%$4.46B$802.80M86.541,246Analyst ForecastNews CoveragePositive NewsGap UpBLCOBausch + Lomb3.8388 of 5 stars$11.86-2.1%$18.82+58.7%-16.5%$4.18B$4.79B-13.0312,500Gap DownSLNOSoleno Therapeutics4.7783 of 5 stars$69.64+3.2%$99.63+43.1%+82.4%$3.19BN/A-20.9830Analyst ForecastGap DownHigh Trading VolumeIRTCiRhythm Technologies0.9047 of 5 stars$100.17-0.2%$119.73+19.5%-8.0%$3.15B$591.84M-27.521,790Positive NewsPRCTPROCEPT BioRobotics2.4041 of 5 stars$50.83-0.8%$94.29+85.5%+4.6%$2.79B$224.50M-26.07430Positive NewsHigh Trading VolumeNVSTEnvista4.3781 of 5 stars$15.27-1.4%$20.18+32.2%-21.0%$2.63B$2.51B-2.3512,700Analyst ForecastAnalyst RevisionNews CoveragePositive NewsGap DownTMDXTransMedics Group2.7598 of 5 stars$69.15+2.2%$122.70+77.4%-5.1%$2.33B$441.54M73.56210 Remove Ads Related Companies and Tools Related Companies STVN Competitors GKOS Competitors NARI Competitors INSP Competitors BLCO Competitors SLNO Competitors IRTC Competitors PRCT Competitors NVST Competitors TMDX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:WRBY) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredCould this be my downfall?I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Warby Parker Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Warby Parker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.